Labetalol vs Nifedipine for High Blood Pressure After Pregnancy

(PEACE Trial)

This trial explores whether labetalol or extended-release nifedipine better controls high blood pressure after childbirth. Researchers believe that nifedipine might maintain lower blood pressure and reduce the need for long-term medication. Participants will be randomly assigned to one of the medications and will have their blood pressure monitored remotely. This study suits those who have experienced high blood pressure after delivery and require medication for management. As a Phase 4 trial, the treatment is already FDA-approved and proven effective, offering participants the chance to benefit from established medications while contributing to research that enhances understanding of their benefits.

The trial requires that participants have not been treated with oral antihypertensive medications before delivery. If you are currently on such medications, you may not be eligible to participate.

Research has shown that both labetalol and nifedipine are generally safe for treating high blood pressure after childbirth. Labetalol has been used safely in new mothers, though some studies suggest it might not be as effective as nifedipine. While there are no major safety concerns for labetalol, monitoring for potential risks remains important.

Nifedipine, however, is known to lower the chance of hospital readmission due to high blood pressure after giving birth. Studies have found it to be a safe option for managing high blood pressure in new mothers, with fewer reported issues.

Unlike the standard treatments for postpartum hypertension, which often include beta-blockers and calcium channel blockers, Labetalol and Nifedipine offer unique benefits. Labetalol is a combined alpha and beta-blocker, providing a dual mechanism of action that can effectively lower blood pressure by reducing heart rate and dilating blood vessels. Nifedipine, on the other hand, is an extended-release calcium channel blocker that allows for once-daily dosing, potentially improving adherence and convenience. Researchers are excited about these treatments because they offer targeted approaches that could optimize blood pressure control with potentially fewer side effects.

This trial will compare the effectiveness of labetalol and nifedipine for managing high blood pressure after pregnancy. Studies have shown that both medications can help manage this condition. However, research suggests that nifedipine might be more effective. Specifically, patients discharged with nifedipine were 88% less likely to be readmitted compared to those taking labetalol. Additionally, labetalol has been associated with a higher likelihood of hospital readmission after childbirth. Overall, nifedipine appears to offer better control of high blood pressure post-pregnancy and may reduce the need for additional treatment.³⁴⁶⁷⁸